CDK3 expression and its clinical significance in human nasopharyngeal carcinoma

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2582-2586

  Wang, Liang ^a   Hu, Hong Y I ^b   Lin, Yi Ling ^b   Zhao, Zhi Xiang ^a   Tan, Lu ^a   Yu, Peng ^b   Wan, Hui Juan ^b   Jin, Zhe ^a   Zheng, Duo ^a  

^a Shenzhen University School of Medicine   (China)

^b PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Biomarker; Cyclin dependent kinase 3; Nasopharyngeal carcinoma; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE 3; BIOLOGICAL MARKER; CDK3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL LINE; CANCER INFILTRATION; CANCER STAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING; DISEASE COURSE; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

BIOLOGICAL MARKERS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 3; DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 84899690736     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2095     Document Type: Article

References (32)

1. Mutirangura A, Tanunyutthawongese C, Pornthanakasem W, et al: Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 76: 770-776, 1997. (Pubitemid 27379745)
2. Wee JT, Ha TC, Loong SL and Qian CN: Is nasopharyngeal cancer really a 'Cantonese cancer'? Chin J Cancer 29: 517-526, 2010.
3. No authors listed: Cancer incidence in five continents. Volume VII. IARC Sci Publ: i-xxxiv, 1-1240, 1997.
4. Chow E, Payne D, O'Sullivan B, et al: Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary? Radiother Oncol 63: 269-274, 2002.
5. al-Sarraf M and McLaughlin PW: Nasopharynx carcinoma: choice of treatment. Int J Radiat Oncol Biol Phys 33: 761-763, 1995.
6. Chua DT, Sham JS and Au GK: A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Oral Oncol 39: 361-366, 2003. (Pubitemid 36379343)
7. Meyerson M, Enders GH, Wu CL, et al: A family of human cdc2-related protein kinases. EMBO J 11: 2909-2917, 1992.
8. Miyata Y, Liu Y, Jankovic V, et al: Cyclin C regulates human hematopoietic stem/progenitor cell quiescence. Stem Cells 28: 308-317, 2010.
9. Rao HV, Thirumangalakudi L and Grammas P: Cyclin C and cyclin dependent kinases 1, 2 and 3 in thrombin-induced neuronal cell cycle progression and apoptosis. Neurosci Lett 450: 347-350, 2009.
10. Sage J, Miller AL, Pérez-Mancera PA, Wysocki JM and Jacks T: Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424: 223-228, 2003. (Pubitemid 36858693)
11. Hofmann F and Livingston DM: Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit. Genes Dev 10: 851-861, 1996. (Pubitemid 26114739)
12. Ren S and Rollins BJ: Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 117: 239-251, 2004.
13. van den Heuvel S and Harlow E: Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054, 1993.
14. Lee JY, Jeong W, Kim JH, et al: Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas. PLoS One 7: e51592, 2012.
15. Zheng D, Cho YY, Lau AT, et al: Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res 68: 7650-7660, 2008.
16. Cho YY, Tang F, Yao K, et al: Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation. Cancer Res 69: 272-281, 2009.
17. Bullrich F, MacLachlan TK, Sang N, et al: Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res 55: 1199-1205, 1995.
18. Mao YP, Li WF, Chen L, et al: A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma. Ai Zheng 28: 1022-1028, 2009 (In Chinese).
19. Malumbres M and Barbacid M: Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641, 2005. (Pubitemid 41540083)
20. Schang LM, Bantly A and Schaffer PA: Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4. J Virol 76: 7724-7735, 2002. (Pubitemid 34760996)
21. Keezer SM and Gilbert DM: Evidence for a pre-restriction point Cdk3 activity. J Cell Biochem 85: 545-552, 2002. (Pubitemid 34465134)
22. Braun K, Hölzl G, Soucek T, Geisen C, Möröy T and Hengstschläger M: Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation. Oncogene 17: 2259-2269, 1998. (Pubitemid 28515378)
23. Alessandrini A, Chiaur DS and Pagano M: Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342-345, 1997. (Pubitemid 27120981)
24. Baba Y, Tsukuda M, Mochimatsu I, et al: Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 25: 414-419, 2001.
25. Pan Y, Zhang Q, Tian L, et al: Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Cancer Res 72: 1890-1900, 2012.
26. Shih LC, Tsai CW, Tsai MH, et al: Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Anticancer Res 32: 1093-1098, 2012.
27. Acikalin MF, Etiz D, Gurbuz MK, Ozudogru E, Canaz F and Colak E: Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma. Med Oncol 29: 742-749, 2012.
28. Hung MC and Link W: Protein localization in disease and therapy. J Cell Sci 124: 3381-3392, 2011.
29. Shapiro GI: Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24: 1770-1783, 2006.
30. Yang ES and Burnstein KL: Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J Biol Chem 278: 46862-46868, 2003. (Pubitemid 37452267)
31. Flores O, Wang Z, Knudsen KE and Burnstein KL: Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition. Endocrinology 151: 896-908, 2010.
32. Bryja V, Pacherník J, Vondrácek J, et al: Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin. Cell Prolif 41: 875-893, 2008.